Humacyte Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Humacyte, Inc. (HUMA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents44.9480.45151.88225.5039.93
Short-Term Investments0.000.002.118.000.00
Cash & Short-Term Investments44.9480.45151.88225.5039.93
Accounts Receivable0.000.000.030.180.11
Inventory0.000.000.000.000.00
Other Current Assets2.922.8318.1015.701.41
Total Current Assets47.8683.28154.21229.3441.45
Non-Current Assets
Property, Plant & Equipment (Net)38.5544.1049.4457.1365.24
Other Non-Current Assets51.460.840.680.000.00
Total Non-Current Assets90.0144.9550.1257.130.00
Total Assets137.87128.22204.30286.53106.69
Current Liabilities
Accounts Payable4.496.498.709.022.27
Short-Term Debt2.920.008.570.002.45
Current Portion of Long-Term Debt0.900.008.570.002.45
Accrued Liabilities11.424.107.112.814.59
Other Current Liabilities12.550.054.233.940.15
Total Current Liabilities19.9518.4419.5811.0511.23
Non-Current Liabilities
Long-Term Debt13.6238.6039.1949.150.82
Other Non-Current Liabilities156.9777.2328.61103.660.14
Total Non-Current Liabilities170.5996.2367.79152.810.00
Total Liabilities190.54114.6887.37164.3636.02
Stockholders' Equity
Common Stock0.010.010.010.010.00
Retained Earnings-686.02-537.31-426.50-414.60-388.10
Additional Paid-in Capital633.33550.85543.46536.740.00
Shares Outstanding130.03103.67103.23103.000.00
Total Stockholders' Equity-52.6713.55116.97122.6470.67
Total Liabilities & Equity137.87128.22204.30286.530.00